[Association of cerebral stroke with a phosphodiesterase 4D (PDE4D) gene polymorphism in the Moscow population].

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 23120769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic polymorphisms for the study of multifactorial stroke

  2008cited by this paper
• Stroke Genetics – Focus on PDE4D Gene

  2008cited by this paper
• Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors

  2007cited by this paper
• Phosphodiesterase 4D Gene, Ischemic Stroke, and Asymptomatic Carotid Atherosclerosis

  2005cited by this paper
• Linkage of Ischemic Stroke to the PDE4D Region on 5q in a Swedish Population

  2005cited by this paper
• The gene encoding phosphodiesterase 4D confers risk of ischemic stroke

  2003cited by this paper
• From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

  2003cited by this paper
• PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.

  2003cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Localization of a susceptibility gene for common forms of stroke to 5q12.

  2002cited by this paper
• 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo.

  2000cited by this paper
• Phosphorylation-mediated Activation and Translocation of the Cyclic AMP-specific Phosphodiesterase PDE4D3 by Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinases

  1999cited by this paper
• Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.

  1999cited by this paper
• Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors.

  1998cited by this paper
• Activation of cAMP–PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury

  1997cited by this paper
• Chromosomal localization of the human and rat genes (PDE4D and PDE4B) encoding the cAMP-specific phosphodiesterases 3 and 4.

  1995cited by this paper
• Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells.

  1994cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper

• The Effect of Beverage Type on the Alcoholic Psychoses Rate in Russia.

  2015cites this paper
• Association between PDE4D gene and ischemic stroke: recent advancements

  2015cites this paper
• On the Role of PDE4D in Cerebral Ischemia

  2014cites this paper